"For and against" factors influencing participation in personalized breast cancer screening programs: a qualitative systematic review until March 2022
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Laza, Celmira
- dc.contributor.author Niño de Guzmán Quispe, Ena Pery
- dc.contributor.author Gea, Montserrat
- dc.contributor.author Plazas, Merideidy
- dc.contributor.author Posso, Margarita
- dc.contributor.author Rué, Montserrat
- dc.contributor.author Castells, Xavier
- dc.contributor.author Román, Marta
- dc.date.accessioned 2025-03-04T17:58:14Z
- dc.date.available 2025-03-04T17:58:14Z
- dc.date.issued 2024
- dc.description.abstract Background: Personalized breast cancer screening is a novel strategy that estimates individual risk based on age, breast density, family history of breast cancer, personal history of benign breast lesions, and polygenic risk. Its goal is to propose personalized early detection recommendations for women in the target population based on their individual risk. Our aim was to synthesize the factors that influence women's decision to participate in personalized breast cancer screening, from the perspective of women and health care professionals. Methods: Systematic review of qualitative evidence on factors influencing participation in personalized Breast Cancer Screening. We searched in Medline, Web of science, Scopus, EMBASE, CINAHL and PsycINFO for qualitative and mixed methods studies published up to March 2022. Two reviewers conducted study selection and extracted main findings. We applied the best-fit framework synthesis and adopted the Multilevel influences on the cancer care continuum model for analysis. After organizing initial codes into the seven levels of the selected model, we followed thematic analysis and developed descriptive and analytical themes. We assessed the methodological quality with the Critical Appraisal Skills Program tool. Results: We identified 18 studies published between 2017 and 2022, conducted in developed countries. Nine studies were focused on women (n = 478) and in four studies women had participated in a personalized screening program. Nine studies focused in health care professionals (n = 162) and were conducted in primary care and breast cancer screening program settings. Factors influencing women's decision to participate relate to the women themselves, the type of program (personalized breast cancer screening) and perspective of health care professionals. Factors that determined women participation included persistent beliefs and insufficient knowledge about breast cancer and personalized screening, variable psychological reactions, and negative attitudes towards breast cancer risk estimates. Other factors against participation were insufficient health care professionals knowledge on genetics related to breast cancer and personalized screening process. The factors that were favourable included the women's perceived benefits for themselves and the positive impact on health systems. Conclusion: We identified the main factors influencing women's decisions to participate in personalized breast cancer screening. Factors related to women, were the most relevant negative factors. A future implementation requires improving health literacy for women and health care professionals, as well as raising awareness of the strategy in society.
- dc.format.mimetype application/pdf
- dc.identifier.citation Laza C, Niño de Guzmán E, Gea M, Plazas M, Posso M, Rué M, et al. "For and against" factors influencing participation in personalized breast cancer screening programs: a qualitative systematic review until March 2022. Arch Public Health. 2024 Feb 22;82(1):23. DOI: 10.1186/s13690-024-01248-x
- dc.identifier.doi http://dx.doi.org/10.1186/s13690-024-01248-x
- dc.identifier.issn 0778-7367
- dc.identifier.uri http://hdl.handle.net/10230/69828
- dc.language.iso eng
- dc.publisher BioMed Central
- dc.relation.ispartof Arch Public Health. 2024 Feb 22;82(1):23
- dc.rights © The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword Breast cancer
- dc.subject.keyword Healthcare professionals
- dc.subject.keyword Participation
- dc.subject.keyword Personalized screening
- dc.subject.keyword Systematic review
- dc.subject.keyword Women
- dc.title "For and against" factors influencing participation in personalized breast cancer screening programs: a qualitative systematic review until March 2022
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion